-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Landos Biopharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2023.
- Landos Biopharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$8.9M, a 47.4% decline year-over-year.
- Landos Biopharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$24.8M, a 18.6% increase year-over-year.
- Landos Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$21.9M, a 44.2% increase from 2022.
- Landos Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$39.3M, a 2.22% decline from 2021.
- Landos Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$38.4M, a 27.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)